Correction: HMGB1 is associated with atherosclerotic plaque composition and burden in patients with stable coronary artery disease (PLoS ONE (2012) 7, 12 (e52081) DOI: 10.1371/journal.pone.0052081);HMGB1 Is Associated with Atherosclerotic Plaque Composition and Burden in Patients with Stable Coronary Artery Disease

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Andrassy, Martin ^a   Volz, H Christian ^a   Schuessler, Alena ^a   Gitsioudis, Gitsios ^a   Hofmann, Nina ^a   Laohachewin, Danai ^a   Wienbrandt, Alexandra R ^a   Kaya, Ziya ^a   Bierhaus, Angelika ^a   Giannitsis, Evangelos ^a   Katus, Hugo A ^a   Korosoglou, Grigorios ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; IOPROMIDE; TROPONIN T;

ADULT; AGE; ARTICLE; ATHEROSCLEROTIC PLAQUE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY CALCIUM SCORE; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DEATH; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PROGNOSIS; RISK FACTOR;

EID: 84871287433     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099246     Document Type: Erratum

References (43)

1. Murray CJ, Lopez AD, (1997) Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349: 1436-1442.
2. Rosamond W, Flegal K, Friday G, Furie K, Go A, et al. (2007) Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115: e69-171.
3. Sanz J, Fayad ZA, (2008) Imaging of atherosclerotic cardiovascular disease. Nature 451: 953-957.
4. Libby P, Ridker PM, Maseri A, (2002) Inflammation and atherosclerosis. Circulation 105: 1135-1143.
5. Korosoglou G, Mueller D, Lehrke S, Steen H, Hosch W, et al. (2010) Quantitative assessment of stenosis severity and atherosclerotic plaque composition using 256-slice computed tomography. Eur Radiol 20: 1841-1850.
6. Hadamitzky M, Distler R, Meyer T, Hein F, Kastrati A, et al. (2011) Prognostic value of coronary computed tomographic angiography in comparison with calcium scoring and clinical risk scores. Circ Cardiovasc Imaging 4: 16-23.
7. Motoyama S, Sarai M, Harigaya H, Anno H, Inoue K, et al. (2009) Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol 54: 49-57.
8. Motoyama S, Kondo T, Sarai M, Sugiura A, Harigaya H, et al. (2007) Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol 50: 319-326.
9. Andrassy M, Volz HC, Igwe JC, Funke B, Eichberger SN, et al. (2008) High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 117: 3216-3226.
10. Andrassy M, Volz HC, Riedle N, Gitsioudis G, Seidel C, et al. (2011) HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarction. J Intern Med 270: 245-253.
11. Korosoglou G, Lehrke S, Mueller D, Hosch W, Kauczor HU, et al. (2011) Determinants of troponin release in patients with stable coronary artery disease: insights from CT angiography characteristics of atherosclerotic plaque. Heart 97: 823-831.
12. Laufer EM, Mingels AM, Winkens MH, Joosen IA, Schellings MW, et al. (2010) The extent of coronary atherosclerosis is associated with increasing circulating levels of high sensitive cardiac troponin T. Arterioscler Thromb Vasc Biol. 30: 1269-1275.
13. Bischoff B, Hein F, Meyer T, Hadamitzky M, Martinoff S, et al. (2009) Impact of a reduced tube voltage on CT angiography and radiation dose: results of the PROTECTION I study. JACC Cardiovasc Imaging 2: 940-946.
14. Yamada S, Yakabe K, Ishii J, Imaizumi H, Maruyama I, (2006) New high mobility group box 1 assay system. Clin Chim Acta 372: 173-178.
15. Libby P, Ridker PM, Hansson GK, (2009) Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 54: 2129-2138.
16. Charo IF, Ransohoff RM, (2006) The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354: 610-621.
17. Lotze MT, Tracey KJ, (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5: 331-342.
18. Volz HC, Kaya Z, Katus HA, Andrassy M, (2010) The role of HMGB1/RAGE in inflammatory cardiomyopathy. Semin Thromb Hemost 36: 185-194.
19. Inoue K, Kawahara K, Biswas KK, Ando K, Mitsudo K, et al. (2007) HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques. Cardiovasc Pathol 16: 136-143.
20. Kalinina N, Agrotis A, Antropova Y, DiVitto G, Kanellakis P, et al. (2004) Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines. Arterioscler Thromb Vasc Biol 24: 2320-2325.
21. Soro-Paavonen A, Watson AM, Li J, Paavonen K, Koitka A, et al. (2008) Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes. Diabetes 57: 2461-2469.
22. Harja E, Bu DX, Hudson BI, Chang JS, Shen X, et al. (2008) Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice. J Clin Invest 118: 183-194.
23. Porto A, Palumbo R, Pieroni M, Aprigliano G, Chiesa R, et al. (2006) Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein. FASEB J 20: 2565-2566.
24. Yan XX, Lu L, Peng WH, Wang LJ, Zhang Q, et al. (2009) Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients. Atherosclerosis 205: 544-548.
25. Omland T, de Lemos JA, Sabatine MS, Christophi CA, Rice MM, et al. (2009) A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 361: 2538-2547.
26. Xu H, Su Z, Wu J, Yang M, Penninger JM, et al. (2010) The alarmin cytokine, high mobility group box 1, is produced by viable cardiomyocytes and mediates the lipopolysaccharide-induced myocardial dysfunction via a TLR4/phosphatidylinositol 3-kinase gamma pathway. J Immunol 184: 1492-1498.
27. Ito T, Kawahara K, Nakamura T, Yamada S, Abeyama K, et al. (2007) High-mobility group box 1 protein promotes development of microvascular thrombosis in rats. J Thromb Haemost 5: 109-116.
28. Schlueter C, Weber H, Meyer B, Rogalla P, Roser K, et al. (2005) Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule. Am J Pathol 166: 1259-1263.
29. Heusch G, Schulz R, Haude M, Erbel R, (2004) Coronary microembolization. J Mol Cell Cardiol 37: 23-31.
30. de Feyter PJ, Ozaki Y, Baptista J, Escaned J, Di Mario C, et al. (1995) Ischemia-related lesion characteristics in patients with stable or unstable angina. A study with intracoronary angioscopy and ultrasound. Circulation 92: 1408-1413.
31. Mann J, Davies MJ, (1999) Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart 82: 265-268.
32. Kanellakis P, Agrotis A, Kyaw TS, Koulis C, Ahrens I, et al. (2011) High-mobility group box protein 1 neutralization reduces development of diet-induced atherosclerosis in apolipoprotein e-deficient mice. Arterioscler Thromb Vasc Biol 31: 313-319.
33. Eisenhardt SU, Habersberger J, Murphy A, Chen YC, Woollard KJ, et al. (2009) Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques. Circ Res 105: 128-137.
34. Wensley F, Gao P, Burgess S, Kaptoge S, Di Angelantonio E, et al. (2011) Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ 342: d548.
35. Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, et al. (2010) C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 375: 132-140.
36. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, et al. (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350: 1387-1397.
37. Jeremias A, Gibson CM, (2005) Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med 142: 786-791.
38. Wang H, Yang H, Tracey KJ, (2004) Extracellular role of HMGB1 in inflammation and sepsis. J Intern Med 255: 320-331.
39. Hoffmann U, Moselewski F, Nieman K, Jang IK, Ferencik M, et al. (2006) Noninvasive assessment of plaque morphology and composition in culprit and stable lesions in acute coronary syndrome and stable lesions in stable angina by multidetector computed tomography. J Am Coll Cardiol 47: 1655-1662.
40. Hammer-Hansen S, Kofoed KF, Kelbaek H, Kristensen T, Kuhl JT, et al. (2009) Volumetric evaluation of coronary plaque in patients presenting with acute myocardial infarction or stable angina pectoris-a multislice computerized tomography study. Am Heart J 157: 481-487.
41. Hosch W, Stiller W, Mueller D, Gitsioudis G, Welzel J, et al. (2011) Reduction of radiation exposure and improvement of image quality with BMI-adapted prospective cardiac computed tomography and iterative reconstruction. Eur J Radiol.
42. Pohle K, Achenbach S, Macneill B, Ropers D, Ferencik M, et al. (2007) Characterization of non-calcified coronary atherosclerotic plaque by multi-detector row CT: comparison to IVUS. Atherosclerosis 190: 174-180.
43. Cormode DP, Roessl E, Thran A, Skajaa T, Gordon RE, et al. (2010) Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles. Radiology 256: 774-782.